BioCryst Pharmaceuticals (United States)
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for BioCryst Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
41%
Total
Publications
206
Total Open
Publications
85
Total
Citations
5.2K
Open Access
Percentage
41%
Total
Publications
206
Total Open
Publications
85
Total
Citations
5.2K
Breakdown
Publisher Open
17%
Both
15%
Other Platform Open
9%
Closed
59%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 30%
20
Hybrid 18%
12
No Guarantees 52%
34
Other Platform Open
Domain 94%
46
Institution 16%
8
Public 10%
5
Other Internet 2%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 46 |
Europe PMC | Domain | 29 |
Semantic Scholar | Public | 5 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 3 |
University of Zurich - Zurich Open Repository and Archive | Institution | 2 |
Washington University School of Medicine - Digital Commons@Becker | Institution | 1 |
Virginia Tech - Virginia Tech Works | Institution | 1 |
Unknown Repository | Other Internet | 1 |
University of Toronto - TSpace | Institution | 1 |
University of North Carolina at Chapel Hill - Carolina Digital Repository | Institution | 1 |